Back
AllianzIM US Large Cap Buffer20 Feb ETF Vs. Collegium Pharmaceutical Industry Stock Comparison
Buy
56
FEBW
AllianzIM US Large Cap Buffer20 Feb ETF
Last Price:
$31.03
Seasonality Move:
3.77%
Sell
45
COLL
Collegium Pharmaceutical
Last Price:
$33.33
Seasonality Move:
-1.63%
Buy
56
AllianzIM US Large Cap Buffer20 Feb ETF (FEBW)
is a Buy
Is AllianzIM US Large Cap Buffer20 Feb ETF a Buy, Sell or Hold?
-
The current AllianzIM US Large Cap Buffer20 Feb ETF [FEBW] share price is $31.04. The Score for FEBW is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
FEBW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
-
The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FEBW Stock Price Chart
What is AllianzIM US Large Cap Buffer20 Feb ETF's stock price today?
-
The AllianzIM US Large Cap Buffer20 Feb ETF share price today is $31.04The current trend is moderately bullish and FEBW is experiencing buying pressure, which is a positive indicator for future bullish movement.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $33.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.
FEBW Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 65.86 | Buy |
Chaikin Money Flow: | 3044 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.9 - 31.02) | Buy |
Bollinger Bands (100): | (30.21 - 30.89) | Buy |
COLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 66.05 | Buy |
Chaikin Money Flow: | 1007158 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.9 - 30.94) | Buy |
Bollinger Bands (100): | (30.52 - 37.92) | Sell |
FEBW Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.03 | Buy |
20-day SMA: | 30.97 | Buy |
50-day SMA: | 30.83 | Buy |
200-day SMA: | 29.91 | Buy |
8-day EMA: | 31.03 | Buy |
20-day EMA: | 30.97 | Buy |
50-day EMA: | 30.82 | Buy |
200-day EMA: | 29.88 | Buy |
COLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.45 | Buy |
20-day SMA: | 29.79 | Buy |
50-day SMA: | 30.91 | Buy |
200-day SMA: | 34.47 | Sell |
8-day EMA: | 30.02 | Buy |
20-day EMA: | 29.94 | Buy |
50-day EMA: | 31.21 | Buy |
200-day EMA: | 32.94 | Buy |
AllianzIM US Large Cap Buffer20 Feb ETF Earnings Growth & FEBW Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.
AllianzIM US Large Cap Buffer20 Feb ETF Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Collegium Pharmaceutical Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |